PGEN
Precigen, Inc.
NASDAQ · Healthcare · Biotechnology · US
$7.10
−0.56%Margins
Gross margin
89.6%
EBITDA margin
-169.1%
EBIT margin
-46.1%
Net margin
-184.0%
FCF margin
-135.1%
-361.9%
Return on equity
-92.6%
Return on assets
-27.8%
Return on invested capital
0.55x
Asset turnover
-$114.2M
Cash from operations
$0.11
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026